We are a Swiss law firm, dedicated to providing legal solutions to business, tax and regulatory matters.
Life Sciences, Pharma, Biotech
Litigation and Arbitration
Our knowledge, expertise & publications
Deals & Cases
20 December 2021
deepCDR Biologics, a Basel, Switzerland-based developer of deep learning technology for antibody discovery and optimization has been acquired by Alloy Therapeutics, a biotechnology ecosystem company. The deepCDR engine combines deep sequencing and deep learning methods with a proprietary mammalian display process to select from a wide range of antibodies and rapidly identify candidates with the highest possible affinity and developability profiles. The company is a spinoff of ETH Zurich and Department of Biosystems Science and Engineering. VISCHER has been advising deepCDR Biologics since foundation as well as on all legal issues related to the sale to Alloy Therapeutics. The VISCHER team includes Matthias Staehelin, Pauline Pfirter and Timothy Woodtli (all Corporate/M&A).
Categories: Corporate and Commercial, Life Sciences, Pharma, Biotech, Mergers & Acquisitions
Vifor Pharma acquires Zurich-based Inositec AG. Inositec develops first-in-class non-dialysis...
GlycoEra AG has closed CHF 45m (USD 49m) Series A financing round, co-led by renowned US and...
MiniNaviDent has received an investment by Straumann Holding AG to further develop and market its...
Opt-in for our regular updates, news, views, insights and more.